Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis.
A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function.
Towards programming immune tolerance through geometric manipulation of phosphatidylserine.
Alpha-methylacyl-CoA racemase deletion has mutually counteracting effects on T-cell responses, associated with unchanged course of EAE.
Transolfactory neuroinvasion by viruses threatens the human brain.
A new in vitro mouse oligodendrocyte precursor cell migration assay reveals a role for integrin-linked kinase in cell motility.
Immunomodulatory Effect of Chymotrypsin in CNS Is Sex-independent: Evidence of Anti-inflammatory Role for IL-17 in EAE.
Seroconversion of neuromyelitis optica spectrum disorder with hyperCKemia: a case report.
White matter disease: Hyaluronidase PH-20 digestion products inhibit remyelination in demyelinating lesions.
[Clinical features and neuroimaging findings of 12 patients with acute disseminated encephalomyelitis involved in corpus callosum].
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.
A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis.
Understanding balance differences in individuals with multiple sclerosis with mild disability: an investigation of differences in sensory feedback on postural control during a Romberg task.
PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE.
Etiologic exploration of magnetic resonance tomographic angiography negative trigeminal neuralgia.
Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis.
Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum.
Minimal supportive treatment in natalizumab-related PML in a MS patient.
[Chronic inflammatory demyelinating polyradiculoneuropathy revealing essential thrombocythemia].
A microcontroller platform for the rapid prototyping of functional electrical stimulation-based gait neuroprostheses.
Impact of the environment on multiple sclerosis.
Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction.
Deep breathing exercises with positive expiratory pressure in patients with multiple sclerosis - a randomized controlled trial.
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Pages
« first
‹ previous
…
450
451
452
453
454
455
456
457
458
…
next ›
last »